User talk:Rshap94

Welcome!
Hello, Rshap94, and welcome to Wikipedia! My name is Adam and I work with the Wiki Education Foundation; I help support students who are editing as part of a class assignment.

I hope you enjoy editing here. If you haven't already done so, please check out the student training library, which introduces you to editing and Wikipedia's core principles. You may also want to check out the Teahouse, a community of Wikipedia editors dedicated to helping new users. Below are some resources to help you get started editing. If you have any questions, please don't hesitate to contact me on my talk page. Adam (Wiki Ed) (talk) 04:11, 12 January 2017 (UTC)

Your submission at Articles for creation: Osteolytic lesion has been accepted
 Osteolytic lesion, which you submitted to Articles for creation, has been created. The article has been assessed as Start-Class, which is recorded on the article's talk page. You may like to take a look at the grading scheme to see how you can improve the article. You are more than welcome to continue making quality contributions to Wikipedia. . Thank you for helping improve Wikipedia! Theroadislong (talk) 23:25, 14 March 2017 (UTC)
 * If you have any questions, you are welcome to ask at the  .
 * If you would like to help us improve this process, please consider.

Peer Review - Mitch White
1. In the summary, I'd replace 'These' for 'Osteolytic' to avoid repetition and using too many pronouns. 2. At the beginning of 'Cellular causes' I would consider leading with a rundown of the various causes instead of going right into one path for osteolytic lesions to develop. 3. If citation [1] pertains to all of 'Cellular causes' I'd consider putting it at the very end of the section. 4. 'Monoclonal antibody treatment RANKI inhibitor' could either use some elaboration, or at least a direct link to the Denosumab wiki. 5. Last sentence of Radiation has a typo - on --> in.

Good work so far! — Preceding unsigned comment added by Mitchwhite5 (talk • contribs) 04:43, 20 March 2017 (UTC)